Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Comprehensive Psychiatry|April 12, 2024
When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)Susan Brown, Cornelia Ploeger, Boliang Guo, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
Trials|November 25, 2017
The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trialJonathan Kingslake, Rebecca Dias, Gerard R Dawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 27, 2021
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trialMichael Browning, Amy C Bilderbeck, Rebecca Dias, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2017
Thymus transplantation for complete DiGeorge syndrome: European experienceE Graham Davies, Melissa Cheung, Kimberly Gilmour, et al.
The Lancet. Psychiatry|July 2, 2025
Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UKMichael Browning, Philip J Cowen, Ushma Galal, et al.
Social Cognitive and Affective Neuroscience|May 5, 2021
How representative are neuroimaging samples? Large-scale evidence for trait anxiety differences between fMRI and behaviour-only research participantsCaroline J Charpentier, Paul Faulkner, Eva R Pool, et al.
Cell|November 25, 2021
From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's diseaseAlastair J H Brown, Sophie J Bradley, Fiona H Marshall, et al.
Pageof 11